Despite the onset of the Delta variant of COVID-19 and widespread hospital staffing shortages, the volume of transcatheter aortic valve replacements (TAVR) in the US grew about 1% in the third quarter compared to the second quarter of 2021, according to a new report from SVB Leerink.
SVB Leerink commissioned a survey of 10 physicians performing TAVR procedures to find out how COVID-19 has ultimately affected the...